DELONG MARK JEFFREY (Senior Vice President) received a stock award from APELLIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/30/2026ACC: 0001492422-26-000077
Officer· Senior Vice President
Since Mar 2021
+36.61K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
36.61K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+36.61K
Price / share
—
Trade value
—
% of position
46.7%
1/28/2026
78.35K→114.96K
Total
Net shares
+36.61K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/28/2026 | A · Award | +36.61K | — | — | 46.7% | 78.35K | 114.96K |
| Total | +36.61K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported